Physician profile
Ryan Wiggins
NPI 1679738512
$4,117.32
in general payments reported to CMS, 2019-2025
16 companies · $536 in 2025
The $536 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $568 · 2020: $45.24 · 2021: $264 · 2022: $1,336 · 2023: $587 · 2024: $781 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,904.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $807.61 | 2022-2025 | Cvi Contact Lens, Clariti Contact Lens, Myday Contact Lens |
| Abbvie INC. | $489.86 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $451.18 | 2022-2024 | Infuse, Biotrue One Day, Alden Scleral Zenlens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $422.23 | 2019-2020 | |
| Alcon Vision LLC | $312.66 | 2019-2025 | Dailies Total1, Precision7, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $283.59 | 2019-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $246.46 | 2021 | |
| Glaukos Corporation | $244.21 | 2022 | |
| Sight Sciences, INC. | $198.47 | 2022 | |
| Biotissue Holdings INC. | $145.83 | 2024 | |
| Allergan, INC. | $116.75 | 2022 | |
| Harrow Eye, LLC | $116.58 | 2025 | Vevye |
| Imperative Care, INC | $95.75 | 2023 | Zoom 88-T Large Distal Platform |
| Tarsus Pharmaceuticals, INC. | $90.73 | 2024 | Xdemvy |
| Carl Zeiss Meditec USA, INC. | $80.17 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $15.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Wiggins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.